Pharmacotherapy for alcoholic smokers

Alcoholism: Clinical and Experimental Research

Volumn 26, Issue 12, 2002, Pages 1939-1941

  Hurt, Richard D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; FLUOXETINE; LEVODOPA; MECAMYLAMINE; NALTREXONE; NICOTINE; SEROTONIN UPTAKE INHIBITOR; ZIMELDINE;

ALCOHOL ABSTINENCE; ALCOHOLISM; BEHAVIOR THERAPY; BLOOD LEVEL; CAUSE OF DEATH; CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; HUMAN; PRIORITY JOURNAL; RELAPSE; SEIZURE; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT INDICATION; WITHDRAWAL SYNDROME;

NICOTIANA TABACUM;

EID: 0036917909     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2002.tb02511.x     Document Type: Conference Paper

References (39)

1. Ascher JA, Cole JO, Colin JN, Feighner JP, Ferris RM, Fibiger HC, Golden RN, Martin P, Potter WZ, Richelson E, Sulser F (1995) Bupropion: A review of its mechanism of antidepressant activity. J Clin Psychiatry 56:395-401.
2. Cornelius JR, Salloum IM, Ehler JG, Jarrett PJ, Cornelius MD, Black A, Perel JM, Thase ME (1997) Double-blind fluoxetine in depressed alcoholic smokers. Psychopharmacol Bull 33:165-170.
3. Cox LS, Patten CA, Niaura RS, Decker P, Rigotti N, Sachs D, Buist AS, Hurt RD (2002) Efficacy of bupropion for relapse prevention in smokers with a past history of major depression. J Clin Psychiatry, in press.
4. Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR (1995) High-dose nicotine patch therapy: Percentage of replacement and smoking cessation. JAMA 274:1353-1358.
5. DiFranza JR, Guerrera MP (1989) Hardcore smokers (letter). JAMA 261:2634-2635.
6. DiFranza JR, Guerrera MP (1990) Alcoholism and smoking. J Stud Alcohol 51:130-135.
7. Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, Heyman RB, Jaen CR, Kottke TE, Lando HA, Mecklenburg RE, Mullen PD, Nett LM, Robinson L, Stitzer ML, Tommasello AC, Villejo L, Wewers ME (2000) Treating Tobacco Use and Dependence. Clinical Practice Guideline. US Department of Health and Human Services, Public Health Service, Rockville, MD.
8. Fredrickson PA, Hurt RD, Lee GM, Wingender L, Croghan IT, Lauger G, Gomez-Dahl L, Offord KP (1995) High dose transdermal nicotine therapy for heavy smokers: Safety, tolerability and measurement of nicotine and cotinine levels. Psychopharmacology 122:215-222.
9. Fryer JD, Lukas RJ (1999) Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine and ibogaine. J Pharmacol Exp Ther 288:88-92.
10. Hayford KE, Patten CA, Rummans TA, Schroeder DR, Offord KP, Croghan IT, Glover ED, Sachs DPL, Hurt RD (1999) Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br J Psychiatry 174:173-178.
11. Hays JT, Hurt RD, Rigotti NA, Niaura R, Gonzales D, Durcan MJ, Sachs DP, Wolter TD, Buist AS, Johnston JA, White JD (2001) Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. A randomized, controlled trial. Ann Intern Med 135:423-433.
12. Hays JT, Schroeder DR, Offord KP, Croghan IT, Patten CA, Hurt RD, Jorenby DE, Fiore MC (1999) Response to nicotine dependence treatment in smokers with current and past alcohol problems. Ann Behav Med 21:244-250.
13. Hughes JR (1996) Clinical implications of the association between smoking and alcoholism, in, Alcohol and Tobacco: From Basic Science to Clinical Practice (NIAAA Research Monograph No. 30) (Fertig JB, Allen JP eds), pp 171-185. National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD.
14. Hughes JR, Lesmes GR, Hatsukami DK, Richmond RL, Lichtenstein E, Jorenby DE, Broughton JO, Fortmann SP, Leischow SJ, McKenna JP, Rennard SI, Wadland WC, Heatley SA (1999) Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine Tob Res 1:169-174.
15. Hurt RD, Ahlskog JE, Croghan GA, Offord KP, Wolter TD, Croghan IT, Moyer TP (2000) Carbidopa/levodopa for smoking cessation: A pilot study with negative results. Nicotine Tob Res 2:71-78.
16. Hurt RD, Dale LC, Fredrickson PA, Caldwell CC, Lee GM, Offord KP, Lauger GG, Marusic Z, Neese LW, Lundberg TG (1994) Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up: One-year outcome and percentage nicotine replacement. JAMA 271:595-600.
17. Hurt RD, Dale LC, Offord KP, Croghan IT, Hays JT, Gomez-Dahl L (1995) Nicotine patch therapy for smoking cessation in recovering alcoholics. Addiction 90:1541-1546.
18. Hurt RD, Offord KP, Croghan IT, Gomez-Dahl L, Kottke TE, Morse RM, Melton LJI (1996) Mortality following inpatient addictions treatment: Role of tobacco use in a community-based cohort. JAMA 275:1097-1103.
19. Hurt RD, Sachs DPL, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 337:1195-1202.
20. Hutchison KE, Monti PM, Rohsenow DJ, Swift RM, Colby SM, Gnys M, Niaura RS, Sirota AD (1999) Effects of naltrexone with nicotine replacement on smoking cue reactivity: Preliminary results. Psychopharmacology 142:139-143.
21. Johnston JA, Lineberry CG, Ascher JA, Davidson J, Khayrallah MA, Feighner JP, Stark P (1991) A 102-center prospective study of seizure in association with bupropion. J Clin Psychiatry 52:450-456.
22. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340:685-691.
23. Jorenby DE, Smith SS, Fiore MC, Hurt RD, Offord KP, Croghan IT, Hays JT, Lewis SF, Baker TB (1995) Varying nicotine patch dose and type of smoking cessation counseling. JAMA 274:1347-1352.
24. Keenan RM, Hatsukami DK, Pickens RW, Gust SW, Strelow LJ (1990) The relationship between chronic ethanol exposure and cigarette smoking in the laboratory and the natural environment. Psychopharmacology 100:77-83.
25. Marks JL, Hill EM, Pomerleau CS, Mudd SA, Blow FC (1997) Nicotine dependence and withdrawal in alcoholic and nonalcoholic eversmokers. J Subst Abuse Treat 14:521-527.
26. McGinnis JM, Foege WH (1993) Actual causes of death in the United States. JAMA 270:2207-2212.
27. Myers M, Brown S (1994) Smoking and health in substance abusing adolescents: A two-year follow-up. Pediatrics 93:561-566.
28. Novy PL, Hughes JR, Jensen JA, Hatsukami DK, Huston J (1999) The efficacy of the nicotine patch in recovering alcoholic smokers, in Problems of Drug Dependence 1998 (NIDA Res Monograph No. 179) (Harris L ed), Vol 91. US Department of Health and Human Services, Washington, DC.
29. Paoletti P, Fornai E, Maggiorelli F, Puntoni R, Viegi G, Carrozzi L, Corlando A, Gustavsson G, Säwe U, Giuntini C (1996) Importance of baseline cotinine plasma values in smoking cessation: Results from a double-blind study with nicotine patch. Eur Respir J 9:643-651.
30. Ravenholt RT (1984) Addiction mortality in the United States. Pop Dev Rev 4:697-725.
31. Rose JE, Behm FM, Westman EC, Levin ED, Stein RM, Ripka GV (1994) Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. Clin Pharmacol Ther 56:86-99.
32. Rose JE, Westman EC, Behm FM (1996) Nicotine/mecamylamine combination treatment for smoking cessation. Drug Dev Res 38:243-256.
33. Sellers EM, Naranjo C, Kadlec K (1987) Do serotonin uptake inhibitors decrease smoking? Observations in a group of heavy drinkers. J Clin Psychopharmacol 7:417-420.
34. Slemmer JE, Martin BR, Damaj MI (2000) Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther 295:321-327.
35. Toneatto A, Sobell LC, Sobell MB, Kozlowski LT (1995) Effect of cigarette smoking on alcohol treatment outcome. J Subst Abuse 7:245-252.
36. Tonnesen P, Paoletti P, Gustavsson G, Russell MA, Saracci R, Gulsvik A, Rijcken B, Sawe U (1999) Higher dosage nicotine patches increase one-year smoking cessation rates: Results from the European CEASE trial. Eur Respir J 13:238-246.
37. Vaillant GE, Schnurr PP, Baron JA, Gerber PD (1991) A prospective study of the effects of cigarette smoking and alcohol abuse on mortality. J Gen Intern Med 6:299-304.
38. Wong GY, Wolter TD, Croghan GA, Croghan IT, Offord KP, Hurt RD (1999) A randomized trial of naltrexone for smoking cessation. Addiction 94:1127-1237.
39. Zevin S, Jacob P, Benowitz NL (1998) Dose-related cardiovascular and endocrine effects of transdermal nicotine. Clin Pharmacol Ther 64:87-95.